Coronary artery calcification in middle-aged women with premature ovarian insufficiency

Autor: Gunning, M.N., Meun, C., Rijn, B.B. van, Maas, A.H.E.M., Benschop, L., Franx, A., Boersma, E., Budde, R.P.J., Appelman, Y., Lambalk, C.B., Eijkemans, M.J.C., Velthuis, B.K., Laven, J.S.E., Fauser, B.C.J.M., Baart, S., Brouwers, L., Budde, R., Cannegieter, S., Dam, V., Daan, N., Eijkemans, R., Fauser, B., Ferrari, M., Groot, C. de, Gunning, M., Hoek, A., Koffijberg, E., Koster, W., Kruit, M., Lagerweij, G., Lambalk, N., Laven, J., Linstra, K., Lugt, A. van der, Maas, A., Brink, A.M. van den, Middeldorp, S., Moons, K., Rijn, B. van, Lennep, J.R. van, Roos-Hesselink, J., Scheres, L., Schouw, Y. van der, Steegers, E., Steegers, R., Terwindt, G., Velthuis, B., Wermer, M., Zick, B., Zoet, G., CREW Consortium

Publikováno v: Clinical Endocrinology, 91, 2, pp. 314-322
Gunning, M N, Meun, C, van Rijn, B B, Maas, A H E M, Benschop, L, Franx, A, Boersma, E, Budde, R P J, Appelman, Y, Lambalk, C B, Eijkemans, M J C, Velthuis, B K, Laven, J S E, Fauser, B C J M & On behalf of the CREW-consortium 2019, ' Coronary artery calcification in middle-aged women with premature ovarian insufficiency ', Clinical Endocrinology, vol. 91, no. 2, pp. 314-322 . https://doi.org/10.1111/cen.14003
Clinical endocrinology, 91(2), 314-322. Wiley-Blackwell
Clinical Endocrinology, 91(2), 314-322. Wiley-Blackwell Publishing Ltd
Clinical Endocrinology, 91(2), 314-322. Wiley-Blackwell
Clinical Endocrinology, 91(2), 314-322. Wiley
Clinical Endocrinology, 91(2), 314-322. WILEY
Clinical Endocrinology, 91, 314-322
Clinical Endocrinology, 91(2), 314-322

Item does not contain fulltext OBJECTIVE: Women with premature ovarian insufficiency (POI) enter menopause before age 40. Early menopause was associated with increased risk for coronary artery disease (CAD), death from cardiovascular disease and all-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff56db366bd8778eed20e50c20a423bf
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85066878135&origin=inward

The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome

Autor: Meun, C., Gunning, M.N., Louwers, Y.V., Peters, H., Roos-Hesselink, J., Lennep, J.R. van, Ochoa, O.L.R., Appelman, Y., Lambalk, N., Boersma, E., Kavousi, M., Fauser, B.C.J.M., Laven, J.S.E., Baart, S., Benschop, L., Brouwers, L., Budde, R., Cannegieter, S., Dam, V., Eijkemans, R., Fauser, B., Ferrari, M., Franx, A., Groot, C. de, Gunning, M., Hoek, A., Koffijberg, E., Koster, W., Kruit, M., Lagerweij, G., Laven, J., Linstra, K., Lugt, A. van der, Maas, A., Brink, A.M. van den, Middeldorp, S., Moons, K.G.M., Rijn, B. van, Scheres, L., Schouw, Y.T. van der, Steegers, E., Steegers, R., Terwindt, G., Velthuis, B., Wermer, M., Zick, B., Zoet, G., CREW Consortium

Publikováno v: Clinical Endocrinology, 92(2), 150-158. Wiley-Blackwell
Clinical Endocrinology, 92, 150-158. Wiley-Blackwell Publishing Ltd
Meun, C, Gunning, M N, Louwers, Y V, Peters, H, Roos-Hesselink, J, Roeters van Lennep, J, Rueda Ochoa, O-L, Appelman, Y, Lambalk, N, Boersma, E, Kavousi, M, Fauser, B C JM, Laven, J S E & on behalf of the CREW consortium 2020, ' The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome ', Clinical Endocrinology, vol. 92, no. 2, pp. 150-158 . https://doi.org/10.1111/cen.14117
Clinical Endocrinology, 92(2), 150-158. Wiley
Clinical Endocrinology, 92, 150-158
Clinical Endocrinology, 92, 2, pp. 150-158
Clinical Endocrinology, 92(2), 150. Wiley-Blackwell
Clinical endocrinology, 92(2), 150-158. Wiley-Blackwell
Clinical Endocrinology

Contains fulltext : 220851.pdf (Publisher’s version ) (Open Access) OBJECTIVES: Contradictory results have been reported regarding the association between polycystic ovary syndrome (PCOS) and cardiovascular disease (CVD). We assessed the cardiometa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1908ecf6c666ea3602d0c0bbb3e534f
https://research.utwente.nl/en/publications/a46f39eb-9c6b-45d1-b0d5-e92f08fb9761

38: Real-world longitudinal trends in clinical outcomes in people with cystic fibrosis using lumacaftor/ivacaftor and tezacaftor/ivacaftor

Autor: Muilwijk, D., Zomer-van Ommen, D., Gulmans, V., Eijkemans, R., van der Ent, C.

Publikováno v: In Journal of Cystic Fibrosis November 2021 20 Supplement 2:S19-S20

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.